CRISPR biotech Intellia leases a big R&D hub in Cambridge, MA

Damian Garde

Therapeutics, a Novartis-backed working on gene-editing technology, leased a sizable research space in the hotbed of , MA.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS